Download PDF
CC BY-NC-ND 4.0 · Indian J Radiol Imaging 2018; 28(02): 200-204
DOI: 10.4103/ijri.IJRI_170_17
Gastrointestinal Radiology and Hepatology

False-positive 18F fluorodeoxyglucose positron emission tomography-avid benign hepatic tumor: Previously unreported in a male patient

Binit Sureka
Department of Radiology, Institute of Liver and Biliary Sciences, New Delhi, India
,
Archana Rastogi
Department of Pathology, Institute of Liver and Biliary Sciences, New Delhi, India
,
Amar Mukund
Department of Radiology, Institute of Liver and Biliary Sciences, New Delhi, India
,
Shiv Kumar Sarin
Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India
› Author Affiliations
Subject Editor: Financial support and sponsorship Nil.
› Further Information
   Permissions and Reprints

Abstract

We report a case of 18F fluorodeoxyglucose (FDG) positron emission tomography (PET)–computed tomography-avid histologically confirmed inflammatory hepatic adenoma in a 77-year-old male patient without any history of steroid, alcohol use. This is the first case report of inflammatory hepatic adenoma in a male patient documented in the published literature showing uptake on 18F-FDG PET. Previous single case report of 18F-FDG PET-avid hepatic adenoma in a male patient was of hepatocyte nuclear factor-1-α subtype.

Keywords

Adenoma - FDG-PET - hepatic - inflammatory - male


Publication History

Article published online:
26 July 2021

© 2018. Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Lee SY, Kingham TP, LaGratta MD, Jessurun J, Cherqui D, Jarnagin WR. et al. PET-avid hepatocellular adenomas: Incidental findings associated with HNF1-α mutated lesions. HPB (Oxford) 2016; 18: 41-8
    CrossrefPubMedGoogle Scholar
  • 2 Patel PM, Alibazoglu H, Ali A, Fordham E, LaMonica G. ’False-positive’ uptake of FDG in a hepatic adenoma. Clin Nucl Med 1997; 22: 490-1
    CrossrefPubMedGoogle Scholar
  • 3 Sumiyoshi T, Moriguchi M, Kanemoto H, Asakura K, Sasaki K, Sugiura T. et al. Liver-specific contrast agent-enhanced magnetic resonance and 18 F-fluorodeoxyglucose positron emission tomography findings of hepatocellular adenoma: Report of a case. Surg Today 2012; 42: 200-4
    CrossrefPubMedGoogle Scholar
  • 4 Magini G, Farsad M, Frigerio M, Serra C, Colecchia A, Jovine E. et al. C-11 acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma. Clin Nucl Med 2009; 34: 659-65
    CrossrefPubMedGoogle Scholar
  • 5 Sanli Y, Bakir B, Kuyumcu S, Ozkan ZG, Gulluoglu M, Bilge O. et al. Hepatic adenomatosis may mimic metastatic lesions of liver with 18F-FDG PET/CT. Clin Nucl Med 2012; 37: 697-8
    CrossrefPubMedGoogle Scholar
  • 6 Buc E, Dupre A, Golffier C, Chabrot P, Flamein R, Dubois A. et al. Positive PET-CT scan in hepatocellular adenoma with concomitant benign liver tumors. Gastroenterol Clin Biol 2010; 34: 338-41
    CrossrefPubMedGoogle Scholar
  • 7 Stephenson JA, Kapasi T, Al-Taan O, Dennison AR. Uptake of (18) FDG by a hepatic adenoma on positron emission tomography. Case Reports Hepatol 2011; 2011: 276402
    CrossrefPubMedGoogle Scholar
  • 8 Fosse P, Girault S, Hoareau J, Testard A, Couturier O, Morel O. Unusual uptake of 18FDG by a hepatic adenoma. Clin Nucl Med 2013; 38: 135-6
    CrossrefPubMedGoogle Scholar
  • 9 Bioulac-Sage P, Laumonier H, Couchy G, Le Bail B, Sa Cunha A, Rullier A. et al. Hepatocellular adenoma management and phenotypic classification: The Bordeaux experience. Hepatology 2009; 50: 481-9
    Google Scholar
  • 10 Dokmak S, Paradis V, Vilgrain V, Sauvanet A, Farges O, Valla D. et al. A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology 2009; 137: 1698-705
    CrossrefPubMedGoogle Scholar
  • 11 Laumonier H, Bioulac-Sage P, Laurent C, Zucman-Rossi J, Balabaud C, Trillaud H. Hepatocellular adenomas: Magnetic resonance imaging features as a function of molecular pathological classification. Hepatology 2008; 48: 808-18
    CrossrefPubMedGoogle Scholar
  • 12 Rebouissou S, Imbeaud S, Balabaud C, Boulanger V, Bertrand-Michel J, Tercé F. et al. HNF1alpha inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and carbohydrate-response element-binding protein (ChREBP) activation. J Biol Chem 2007; 282: 14437-46
    CrossrefPubMedGoogle Scholar
  • 13 Long NM, Smith CS. Causes and imaging features of false positives and false negatives on F-PET/CT in oncologic imaging. Insights Imaging 2011; 2: 679-98
    CrossrefPubMedGoogle Scholar
  • 14 Khan MA, Combs CS, Brunt EM, Lowe VJ, Wolverson MK, Solomon H. et al. Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. J Hepatol 2000; 32: 792-7
    CrossrefPubMedGoogle Scholar
  • 15 Shiomi S, Kawabe J. Clinical applications of positron emission tomography in hepatic tumors. Hepatol Res 2011; 41: 611-7
    CrossrefPubMedGoogle Scholar
  • 16 Lim D, Lee SY, Lim KH, Chan CY. Hepatic adenoma mimicking a metastatic lesion on computed tomography-positron emission tomography scan. World J Gastroenterol 2013; 19: 4432-6
    CrossrefPubMedGoogle Scholar
  • 17 Bioulac-Sage P, Balabaud C, Zucman-Rossi J. Subtype classification of hepatocellular adenoma. Dig Surg 2010; 27: 39-45
    CrossrefPubMedGoogle Scholar
  • 18 Rhim H, Lim HK, Kim YS, Choi D. Percutaneous radiofrequency ablation of hepatocellular adenoma: Initial experience in 10 patients. J Gastroenterol Hepatol 2008; 23: e422-7
    CrossrefPubMedGoogle Scholar